Regulatory & Policy
FDA Moves to Strip Two Petroleum-Based Color Additives From Food
The FDA's dual action on Orange B and Citrus Red No. 2 signals continued regulatory momentum around synthetic dye elimi…
Regulatory & Policy 21 stories
Regulatory & Policy
Hospital Nutrition Pledge Signals Food-as-Medicine Shift
Tampa General's formal commitment to whole-food, nutrition-centered care could reshape how healthcare systems leverage …
Regulatory & Policy
Editor's Note: This Release Falls Outside Functional News Coverage
Functional News covers ingredients, finished formulations, and regulatory developments in functional foods, dietary sup…
Regulatory & Policy
Editor's Note: This Release Falls Outside Functional News Coverage
Functional News covers ingredients, finished formulations, clinical nutrition, and supplement regulation — not hospital…
Regulatory & Policy
Functional News: Outside Editorial Scope — Submission Declined
Submitted content covers hospital AI and precision medicine infrastructure — outside the functional foods and nutraceut…
Regulatory & Policy
Editor's Note: This Release Falls Outside Functional News Coverage
The submitted press release covers an XR/metaverse medical technology investment — outside the functional foods and nut…
Regulatory & Policy
BCC Research: AI Investment Hits $700B Amid Regulatory Surge
Regulatory frameworks like the EU AI Act are accelerating compliance demands that increasingly affect ingredient tracea…
Regulatory & Policy
Editor's Note: Press Release Outside Functional Foods Scope
Functional News covers ingredients, formulations, clinical nutrition, and dietary supplements — not implantable medical…
Regulatory & Policy
Hemp Industry Faces Make-or-Break Congressional Window This Summer
With Farm Bill negotiations accelerating, hemp operators face a narrow lobbying window that could redefine THC threshol…
Regulatory & Policy
Off-Topic Submission: No Functional Food Content Detected
Cellectis' lasme-cel and eti-cel are oncology biologics, not dietary supplements, functional foods, or nutraceuticals.
Regulatory & Policy
Optimi Health Ships Psilocybin to UK for Phase 2 Trial
The cross-border transfer required dual regulatory authorization from Health Canada and the UK Home Office, marking a p…
Regulatory & Policy
FDA Grants Orphan Drug Status to Low-Sodium Oxybate for Sleep Disorder
The designation hinges on a plausible clinical superiority argument over existing oxybate therapies — a regulatory path…